Figure 5.
Figure 5. Cumulative incidence of relapse after serologically HLA-matched or one-locus–mismatched HSCT. (A) Standard-risk disease. (B) High-risk disease.

Cumulative incidence of relapse after serologically HLA-matched or one-locus–mismatched HSCT. (A) Standard-risk disease. (B) High-risk disease.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal